Search - tctmd.com

Displaying 1 - 20 of 38

Sort: Relevancy | Date

News Features

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

Michael O'Riordan

October 17, 2025

News Conference News ACC 2025

Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP

Michael O'Riordan

April 01, 2025

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

News Daily News

Acute HF Patients Live Longer When Seen by Specialists

Michael O'Riordan

August 09, 2024

News Conference News ESC Heart Failure 2024

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

Michael O'Riordan

May 21, 2024

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Conference News ESC Heart Failure 2024

Remote Monitoring in Real-world HF Cuts All-Cause Mortality: TELESAT-HF

Michael O'Riordan

May 12, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Daily News

PA Catheters in Cardiogenic Shock: Patchy Usage, Potential Gains

Shelley Wood

June 22, 2023

News Daily News

Journal Series Explores How Eroding Abortion Access Impacts the HF Community

Todd Neale

June 15, 2023

News Conference News ESC Heart Failure 2023

CardioMEMS Beats Standard Care in First European RCT: MONITOR-HF

Shelley Wood

May 21, 2023

News Conference News EHRA 2023

Novel Score Identifies HF Patients With AF Who Respond to Ablation

Michael O'Riordan

April 19, 2023

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Shelley Wood

March 20, 2023

News Daily News

For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread

Michael O'Riordan

January 30, 2023

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Conference News ESC 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Michael O'Riordan

August 27, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

Advertisement

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Acute HF Patients Live Longer When Seen by Specialists

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Remote Monitoring in Real-world HF Cuts All-Cause Mortality: TELESAT-HF

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

PA Catheters in Cardiogenic Shock: Patchy Usage, Potential Gains

Journal Series Explores How Eroding Abortion Access Impacts the HF Community

CardioMEMS Beats Standard Care in First European RCT: MONITOR-HF

Novel Score Identifies HF Patients With AF Who Respond to Ablation

TEER or VAD/Transplant in the Advanced HF Patient With MR?

For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content